共 50 条
- [1] Effectiveness of pazopanib and SBRT in metastatic renal cell carcinoma World Journal of Urology, 2018, 36 : 1797 - 1798
- [5] Pazopanib or sunitinib for metastatic renal-cell carcinoma? LANCET ONCOLOGY, 2013, 14 (11): : E442 - E442
- [6] Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom PLOS ONE, 2017, 12 (06):
- [7] Evaluation of the effectiveness and tolerability of sunitinib and pazopanib in the first line treatment of metastatic renal cell carcinoma ONCOLOGY IN CLINICAL PRACTICE, 2022, 18 (04): : 226 - 234
- [8] Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 722 - 731
- [9] Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma? Current Oncology Reports, 2010, 12 : 77 - 79